These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12369064)

  • 1. Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
    Coast J; Smith R; Karcher AM; Wilton P; Millar M
    Health Econ; 2002 Oct; 11(7):637-47. PubMed ID: 12369064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation?
    Coast J; Smith RD; Millar MR
    Health Econ; 1996; 5(3):217-26. PubMed ID: 8817296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of measures to assess prevention and control of AMR in hospitals.
    Flanagan M; Ramanujam R; Sutherland J; Vaughn T; Diekema D; Doebbeling BN
    Med Care; 2007 Jun; 45(6):537-44. PubMed ID: 17515781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative review of the current evidence on the relationship between hand hygiene interventions and the incidence of health care-associated infections.
    Backman C; Zoutman DE; Marck PB
    Am J Infect Control; 2008 Jun; 36(5):333-48. PubMed ID: 18538700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic burden of antimicrobial resistance.
    Maragakis LL; Perencevich EN; Cosgrove SE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.
    Diazgranados CA; Cardo DM; McGowan JE
    Int J Antimicrob Agents; 2008 Jul; 32(1):1-9. PubMed ID: 18550343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and process factors affecting the implementation of antimicrobial resistance prevention and control strategies in U.S. hospitals.
    Chou AF; Yano EM; McCoy KD; Willis DR; Doebbeling BN
    Health Care Manage Rev; 2008; 33(4):308-22. PubMed ID: 18815496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation.
    Drummond MF; Aguiar-Ibanez R; Nixon J
    Singapore Med J; 2006 Jun; 47(6):456-61; quiz 462. PubMed ID: 16752012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the antimicrobial agent susceptibility study raised in a representative, cross-sectional monitoring study on a national basis.
    Kaspar H
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():69-79. PubMed ID: 16531116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit.
    Huskins WC
    Curr Opin Crit Care; 2007 Oct; 13(5):572-7. PubMed ID: 17762238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of antimicrobial therapy: what should we be using?
    Southwood LL
    Vet Clin North Am Equine Pract; 2006 Aug; 22(2):279-96, vii. PubMed ID: 16882476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pets and antimicrobial resistance.
    Umber JK; Bender JB
    Vet Clin North Am Small Anim Pract; 2009 Mar; 39(2):279-92. PubMed ID: 19185194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals.
    Wallmann J
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():81-6. PubMed ID: 16530479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention.
    Bell DM
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S245-50. PubMed ID: 11524727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals.
    MacKenzie FM; Bruce J; Struelens MJ; Goossens H; Mollison J; Gould IM;
    Clin Microbiol Infect; 2007 Mar; 13(3):269-76. PubMed ID: 17391381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.